Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

LY2405319, an analog of fibroblast growth factor 21 ameliorates α-smooth muscle actin production through inhibition of the succinate-G-protein couple receptor 91 (GPR91) pathway in mice.

Le CT, Nguyen G, Park SY, Choi DH, Cho EH.

PLoS One. 2018 Feb 14;13(2):e0192146. doi: 10.1371/journal.pone.0192146. eCollection 2018.

2.

Pathway Analysis of Gene Expression of E14 Versus E18 Fetal Fibroblasts.

Hu MS, Borrelli MR, Januszyk M, Luan A, Malhotra S, Walmsley GG, Hong WX, Tevlin R, Gurtner GC, Longaker MT, Lorenz HP.

Adv Wound Care (New Rochelle). 2018 Jan 1;7(1):1-10. doi: 10.1089/wound.2017.0763.

3.

Hepatic Fibrosis in Dogs.

Eulenberg VM, Lidbury JA.

J Vet Intern Med. 2018 Jan;32(1):26-41. doi: 10.1111/jvim.14891. Epub 2017 Nov 30. Review.

4.

Glucocorticoids Cause Gender-Dependent Reversal of Hepatic Fibrosis in the MDR2-Knockout Mouse Model.

Petrescu AD, Grant S, Frampton G, Kain J, Hadidi K, Williams E, McMillin M, DeMorrow S.

Int J Mol Sci. 2017 Nov 10;18(11). pii: E2389. doi: 10.3390/ijms18112389.

5.

IL-32γ promotes integrin αvβ6 expression through the activation of NF-κB in HSCs.

Liu H, Pan X, Cao H, Shu X, Sun H, Lu J, Liang J, Zhang K, Zhu F, Li G, Zhang Q.

Exp Ther Med. 2017 Oct;14(4):3880-3886. doi: 10.3892/etm.2017.4956. Epub 2017 Aug 17.

6.

Anti-fibrotic Effects of Synthetic Oligodeoxynucleotide for TGF-β1 and Smad in an Animal Model of Liver Cirrhosis.

Kim JY, An HJ, Kim WH, Gwon MG, Gu H, Park YY, Park KK.

Mol Ther Nucleic Acids. 2017 Sep 15;8:250-263. doi: 10.1016/j.omtn.2017.06.022. Epub 2017 Jul 3.

7.

Antrodia Cinnamomea Reduces Carbon Tetrachloride-induced Hepatotoxicity In Male Wister Rats.

Shih YL, Wu MF, Lee CH, Yeh MY, Chou J, Liu JY, Lu HF, Huang YP, Liao NC, Chung JG.

In Vivo. 2017 Sep-Oct;31(5):877-884.

8.

Silica nanoparticles induce liver fibrosis via TGF-β1/Smad3 pathway in ICR mice.

Yu Y, Duan J, Li Y, Li Y, Jing L, Yang M, Wang J, Sun Z.

Int J Nanomedicine. 2017 Aug 21;12:6045-6057. doi: 10.2147/IJN.S132304. eCollection 2017.

9.

Platelets in liver disease, cancer and regeneration.

Kurokawa T, Ohkohchi N.

World J Gastroenterol. 2017 May 14;23(18):3228-3239. doi: 10.3748/wjg.v23.i18.3228. Review.

10.

Iron overload correlates with serum liver fibrotic markers and liver dysfunction: Potential new methods to predict iron overload-related liver fibrosis in thalassemia patients.

Wang M, Liu R, Liang Y, Yang G, Huang Y, Yu C, Sun K, Lai Y, Xia Y.

United European Gastroenterol J. 2017 Feb;5(1):94-103. doi: 10.1177/2050640616646525. Epub 2016 Jun 23.

11.

Correlation of Chitinase 3-Like 1 Single Nucleotide Polymorphisms with Hepatocellular Carcinoma in Taiwan.

Huang WS, Lin HY, Yeh CB, Chen LY, Chou YE, Yang SF, Liu YF.

Int J Med Sci. 2017 Feb 7;14(2):136-142. doi: 10.7150/ijms.17754. eCollection 2017.

12.

Force-dependent breaching of the basement membrane.

Chang TT, Thakar D, Weaver VM.

Matrix Biol. 2017 Jan;57-58:178-189. doi: 10.1016/j.matbio.2016.12.005. Epub 2016 Dec 23. Review.

13.

IRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans.

Alzaid F, Lagadec F, Albuquerque M, Ballaire R, Orliaguet L, Hainault I, Blugeon C, Lemoine S, Lehuen A, Saliba DG, Udalova IA, Paradis V, Foufelle F, Venteclef N.

JCI Insight. 2016 Dec 8;1(20):e88689.

14.

Diffusion-weighted imaging of the liver: Current applications.

Saito K, Tajima Y, Harada TL.

World J Radiol. 2016 Nov 28;8(11):857-867. Review.

15.

Current status and future prospects of mesenchymal stem cell therapy for liver fibrosis.

Guo Y, Chen B, Chen LJ, Zhang CF, Xiang C.

J Zhejiang Univ Sci B. 2016 Nov.;17(11):831-841. Review.

16.

Noninvasive mapping of the redox status of dimethylnitrosamine-induced hepatic fibrosis using in vivo dynamic nuclear polarization-magnetic resonance imaging.

Kawano T, Murata M, Hyodo F, Eto H, Kosem N, Nakata R, Hamano N, Piao JS, Narahara S, Akahoshi T, Hashizume M.

Sci Rep. 2016 Sep 2;6:32604. doi: 10.1038/srep32604.

17.

Alcohol Disrupts Human Liver Stem/Progenitor Cell Proliferation and Differentiation.

Shi X, Chang CC, Basson MD, Upham BL, Wei L, Zhang P.

J Stem Cell Res Ther. 2014 May;4(5). pii: 205. Epub 2014 May 12.

18.

Murine Models of Nonalcoholic Fatty Liver Disease and Steatohepatitis.

Ninomiya M, Kondo Y, Shimosegawa T.

ISRN Hepatol. 2012 Dec 12;2013:237870. doi: 10.1155/2013/237870. eCollection 2013. Review.

19.

Suppressive effect of microRNA-29b on hepatic stellate cell activation and its crosstalk with TGF-β1/Smad3.

Liang C, Bu S, Fan X.

Cell Biochem Funct. 2016 Jul;34(5):326-33. doi: 10.1002/cbf.3193. Epub 2016 Jun 7.

20.

Diagnostic value of anti-smooth muscle antibodies and liver enzymes in differentiation of extrahepatic biliary atresia and idiopathic neonatal hepatitis.

Rafeey M, Saboktakin L, Hasani JS, Naghashi S.

Afr J Paediatr Surg. 2016 Apr-Jun;13(2):63-8. doi: 10.4103/0189-6725.182558.

Supplemental Content

Support Center